Myo-Inositol supplementation has increased in popularity, with more and more clinicians and specialists advocating for its use. Pillar Healthcare’s Myo-Inositol contains 4g (4,000mg) per individual sachet. It is free from any additives or excipients and it is in its purest, unadulterated form.
The individual sachets allow for convenience, time specific dosing, with assurances that you are consuming the advised amount with every serving.
Pillar’s Myo-Inositol product is produced in the European Union, it is Gluten and Dairy free and because we have added nothing to this nutrient, it is in its natural vegan form.
As shown in numerous examinations, Myo-Inositol is the most abundant form of inositol in humans and through various enzymatical processes, it can be changed into various derivatives. This is one of the reasons why it has become the preferred inositol supplement and why it was chosen by our nutritional and health experts.
In an editorial provided by the British Medical Journal, the noted authors stated, “Myo-inositol should be considered in patients with insulin resistance, metabolic syndrome, type 1 diabetes, type 2 diabetes, PCOS and those with or at risk of gestational diabetes. Elevated levels of glucose reduce Myo-inositol levels in tissues and increase its breakdown and elimination via the kidneys. Myo-inositol has been used safely for decades in many studies in those with insulin resistance and PCOS.”
PCOS affects 5%–21% of women during their reproductive life. Insulin resistance is a frequent finding in patients with PCOS, regardless of body mass index (BMI). Indeed, around 70%–80% of women with PCOS and central obesity and 15%–30% of lean women with PCOS have insulin resistance and compensatory hyperinsulinaemia (means the amount of insulin in the blood is higher than what’s considered healthy).
Myo-Inositol plays a crucial role in fertility and in supporting physiological gestation, according to a recent large examination of Inositol, published in “Pharmaceuticals”, a peer-reviewed journal of medicinal chemistry and related drug sciences. As second messenger of gonadotropins (FSH, LH, hC) and insulin, it supports the correct development of oocytes and the progression of embryogenesis. Available evidence demonstrates that the supplementation with myo-inositol enhances the probability of achieving pregnancy and reduces the onset of adverse maternal effects and neonatal outcomes. Specifically, in the pursuit of pregnancy, Myo-Inositol was able to induce ovulation and restore the physiological menstrual cycle in infertile women, particularly in those with PCOS. Moreover, Myo-Inositol supplementation is also useful for women undergoing ART, improving oocyte and embryo quality. During pregnancy, Myo-Inositol reduces the risk of altered metabolic conditions like gestational diabetes, which may lead to miscarriages.